Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized controlled trial.

CONCLUSIONS: The primary endpoint, moist desquamation, was not significantly different between treatment arms. PMID: 28062087 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28062087?dopt=Abstract

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - January 2, 2017 Category: Radiology Authors: Paelinck L, Gulyban A, Lakosi F, Vercauteren T, De Gersem W, Speleers B, Monten C, Mulliez T, Berkovic P, van Greveling A, Decoster F, Coucke P, De Neve W, Veldeman L Tags: Radiother Oncol Source Type: research